Suspended

Egg Consumption During Pregnancy for Child Growth in Rwanda

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
Study Aim

The study aims to evaluate how eating eggs during pregnancy affects the growth of newborns in Rwanda by measuring their length at birth.

What is being tested

Egg consumption

Dietary Supplement
Who is being recruted

Urogenital Diseases+9

+ Female Urogenital Diseases and Pregnancy Complications

+ Fetal Diseases

From 18 to 44 Years
See all eligibility criteria
How is the trial designed

Services Research Study

Interventional
Study Start: May 2024
See protocol details

Summary

Principal SponsorUniversity of Florida
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: May 2, 2024

Actual date on which the first participant was enrolled.

This study focuses on improving the health and development of children in the Nyagatare District of Rwanda by exploring the impact of maternal egg consumption during pregnancy. In many low- and middle-income countries, diets often lack diversity and adequate nutrition, which can lead to malnutrition and stunted growth, especially in children. This trial aims to see if consuming two eggs daily during pregnancy can enhance fetal growth and brain development, leading to healthier birth outcomes. Eggs are rich in essential nutrients that support growth and development, and this study seeks to fill a gap in research by examining the direct effects of maternal egg consumption on child health. Participants in this study are pregnant women who are randomly assigned to two groups: one group receives two eggs daily, while the other continues their typical diet. Eggs are prepared and distributed at local health centers and community sites to ensure safety and accessibility. These women are monitored through regular clinic visits and follow-ups after childbirth to assess the growth and development of their children. The study measures outcomes like birth length and brain development to determine the benefits of the nutritional intervention. By doing so, the study hopes to provide insights into effective dietary strategies for improving maternal and child health in regions where malnutrition is common.

Official TitleDEUX OEUFs:Cracking the Potential of Eggs to Improve Child Growth and Development
NCT06405360
Principal SponsorUniversity of Florida
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

464 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Services Research Study

These studies look at how healthcare is delivered, managed, and organized. They aim to improve care quality, patient experience, and access to treatment.



Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Female

Biological sex of participants that are eligible to enroll.

From 18 to 44 Years

Range of ages for which participants are eligible to join.

Healthy volunteers allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsFetal DiseasesFetal Growth RetardationGrowth DisordersInfant Nutrition DisordersCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesNutrition DisordersNutritional and Metabolic DiseasesPathologic ProcessesPregnancy ComplicationsPathological Conditions, Signs and Symptoms

Criteria

Inclusion Criteria: * Lives in study area (catchment area of Karangazi Health Center and Ndama Health Center) * Confirmed viable intrauterine pregnancy (confirmed via ultrasound) * Aged between 18-44 years * 9-14 weeks gestation (confirmed via ultrasound, up to 13 weeks +6 days) * Agrees to participate with informed consent Exclusion Criteria: * Intention to move outside the study area in next 12 months * Intention to deliver at a location outside of Eastern Province Nyagatare District * Any known adverse reaction to eating eggs or porridge ingredients * Any condition that could affect the ability to comply with the study requirements or understand the informed consent process * Participation in other clinical trials (to avoid burden and potential interactions between interventions) * Any individual unable or unwilling to comply with the study requirements, such as attending regular follow-up visits or adhering to prescribed nutritional supplementation.

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

One single intervention group is designated in this study

This study does not include a placebo group 

Treatment Groups

Group I

Experimental
Mothers in the intervention arm will receive an animal-source food supplement of two eggs per day from the day of enrollment during the first trimester through childbirth.

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Suspended

Ndama Health Center

Nyagatare, RwandaOpen Ndama Health Center in Google Maps
SuspendedOne Study Center